Company Profile

Olfax LLC
Profile last edited on: 1/25/2024      CAGE: 8WCV8      UEI: TVWUUJVHAD33

Business Identifier: Nasally administered therapeutics
Year Founded
2021
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

16 Biltmore Avenue Suite 300
Asheville, NC 28803
   (603) 667-3484
   N/A
   www.olfaxmedical.com
Location: Single
Congr. District: 11
County: Buncombe

Public Profile

Developing and commercializing therapeutics for central nervous system conditions, Olfax Medical is developing nasally administered therapeutics designed to help patients avoid the harmful and addictive side effects of systemic pharmaceuticals. The firm's product pipeline is based on a simple-to-use, handheld device that accurately delivers medication to the upper-posterior nasal cavity without the use of propellants.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $336,946
Project Title: Development of an intranasal, direct to nerve treatment for headache disorders

Key People / Management

  Jonathan Beckwith

Company News

There are no news available.